BioSpace News Archive

Drug Development

vTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study

Results Found TTP399 Demonstrated a Statistically Significant Improvement in HbA1c Compared to Placebo without Hypoglycemia or Hyperlipidemia

January 16, 2019
·
5 min read
Drug Development

Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia

Phase 1 clinical trial to evaluate safety and tolerability of SYNB1020 in healthy volunteers demonstrated safety, clearance and proof of mechanism

January 16, 2019
·
7 min read
Biotech Beach

EUREKA VAPOR Launches Highest Potency Pure Vape Line At Leading California Dispensary Under New California License

New Dispensary/ Stockist List Includes KOREATOWN COLLECTIVE

January 16, 2019
·
2 min read
BioMidwest

Novus to Showcase Poultry Solutions at IPPE

Gut health and application processes are key topics from the global nutrition and health company

January 16, 2019
·
3 min read
Business

Stimwave Announces Completion of the SURF Randomized Clinical Trial of First Minimally Invasive, Miniature Wireless SCS System

Positive Six-Month Results Demonstrate Substantial Benefits over Historical Conventional Battery Legacy System Reported Outcomes

January 16, 2019
·
4 min read
Deals

Mirati Therapeutics Announces Proposed Public Offering Of Common Stock - January 16, 2019

Mirati Therapeutics, Inc. announced that it intends to offer and sell, subject to market and other conditions, $75.0 million of shares of its common stock in an underwritten public offering.

January 16, 2019
·
4 min read
Business

First Patients in the Middle East Treated with Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

Introduction of Orbital Atherectomy in the Middle East by OrbusNeich® Expands Treatment Options for Patients with Complex Coronary Artery Disease

January 16, 2019
·
6 min read
Business

Universal Health Services, Inc. Announces Dividend Payable on March 15, 2019

Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.10 per share on March 15, 2019 to shareholders of record as of March 1, 2019.

January 16, 2019
·
1 min read
Deals

Cryopreservation company, Acorn Biolabs closes $3.3M seed funding and ramps towards consumer launch

The world’s first non-invasive home-cell collection service will allow consumers to easily collect live cells for future therapeutic uses.

January 16, 2019
·
6 min read
BioCapital

CAQH 2018 Index: Healthcare Industry Continues Progress Automating Business Processes Amid Increase in Transaction Volume

CAQH released the 2018 Index today, which reveals that the healthcare industry continues to make progress automating business processes.

January 16, 2019
·
2 min read